0001729427 2025-01-01 2025-12-31 0001729427 2025-06-30 0001729427 2026-04-27 iso4217:USD shares true 2025 FY Filed to amend Items 10 through 14 0001729427 10-K/A true 2025-12-31 --12-31 false 001-39126 CNS Pharmaceuticals, Inc. NV 82-2318545 2100 West Loop South Suite 900 Houston TX 77027 800 946-9185 Common Stock CNSP NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 8780000 811449 true We do not grant equity awards in anticipation of the release of <span id="xdx_90C_eecd--AwardTmgMnpiCnsdrdFlag_dbT_c20250101__20251231_zEqes8MeuPzg">material nonpublic information</span> that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. During the last completed fiscal year, we have not made awards to any named executive officer or director during the period beginning four business days before and ending one business day after the filing of a period report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. true